While CDKN2A expression was still present in the hemizygous case, a subsequent patient-derived xenograft (PDX) model established from this tumor (Supplementary Fig. 4) showed full loss of expression, even extending to other nearby genes (Fig. 2e, Supplementary Fig. 3a). This evidence concerns the gene CDKN2A and neoplasm.